ARCHIVES

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

Two Court Rulings Conflict In Paclitaxel Patent Battle.

January 18, 2002

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

Abstracts From AACR Annual Meeting

May 28, 1976

Danish Researchers Post Long-Awaited Aranesp Results–Ever So Discreetly.

February 16, 2007

New Chemotherapy, Other Modality Progress Described

March 30, 1979

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013